234 related articles for article (PubMed ID: 36555159)
21. Optimization of 5' Untranslated Region of Modified mRNA for Use in Cardiac or Hepatic Ischemic Injury.
Sultana N; Hadas Y; Sharkar MTK; Kaur K; Magadum A; Kurian AA; Hossain N; Alburquerque B; Ahmed S; Chepurko E; Zangi L
Mol Ther Methods Clin Dev; 2020 Jun; 17():622-633. PubMed ID: 32300609
[TBL] [Abstract][Full Text] [Related]
22. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction.
Zangi L; Lui KO; von Gise A; Ma Q; Ebina W; Ptaszek LM; Später D; Xu H; Tabebordbar M; Gorbatov R; Sena B; Nahrendorf M; Briscoe DM; Li RA; Wagers AJ; Rossi DJ; Pu WT; Chien KR
Nat Biotechnol; 2013 Oct; 31(10):898-907. PubMed ID: 24013197
[TBL] [Abstract][Full Text] [Related]
23. Cell-mediated delivery of VEGF modified mRNA enhances blood vessel regeneration and ameliorates murine critical limb ischemia.
Yu Z; Witman N; Wang W; Li D; Yan B; Deng M; Wang X; Wang H; Zhou G; Liu W; Sahara M; Cao Y; Fritsche-Danielson R; Zhang W; Fu W; Chien KR
J Control Release; 2019 Sep; 310():103-114. PubMed ID: 31425721
[TBL] [Abstract][Full Text] [Related]
24. Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression.
Turnbull IC; Eltoukhy AA; Fish KM; Nonnenmacher M; Ishikawa K; Chen J; Hajjar RJ; Anderson DG; Costa KD
Mol Ther; 2016 Feb; 24(1):66-75. PubMed ID: 26471463
[TBL] [Abstract][Full Text] [Related]
25. Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target.
Son Y; Zhu W
Mol Diagn Ther; 2023 Mar; 27(2):129-140. PubMed ID: 36512179
[TBL] [Abstract][Full Text] [Related]
26. Optimizing Modified mRNA
Hadas Y; Sultana N; Youssef E; Sharkar MTK; Kaur K; Chepurko E; Zangi L
Mol Ther Methods Clin Dev; 2019 Sep; 14():300-305. PubMed ID: 31508439
[TBL] [Abstract][Full Text] [Related]
27. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles.
Evers MJW; Du W; Yang Q; Kooijmans SAA; Vink A; van Steenbergen M; Vader P; de Jager SCA; Fuchs SA; Mastrobattista E; Sluijter JPG; Lei Z; Schiffelers R
J Control Release; 2022 Mar; 343():207-216. PubMed ID: 35077739
[TBL] [Abstract][Full Text] [Related]
28. Long Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair.
Ponnusamy M; Liu F; Zhang YH; Li RB; Zhai M; Liu F; Zhou LY; Liu CY; Yan KW; Dong YH; Wang M; Qian LL; Shan C; Xu S; Wang Q; Zhang YH; Li PF; Zhang J; Wang K
Circulation; 2019 Jun; 139(23):2668-2684. PubMed ID: 30832495
[TBL] [Abstract][Full Text] [Related]
29. RhoE Fine-Tunes Inflammatory Response in Myocardial Infarction.
Dai Y; Song J; Li W; Yang T; Yue X; Lin X; Yang X; Luo W; Guo J; Wang X; Lai S; Andrade KC; Chang J
Circulation; 2019 Feb; 139(9):1185-1198. PubMed ID: 30586715
[TBL] [Abstract][Full Text] [Related]
30. Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery.
Żak MM; Kaur K; Yoo J; Kurian AA; Adjmi M; Mainkar G; Yoon S; Zangi L
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765147
[TBL] [Abstract][Full Text] [Related]
31. Lin28a cardiomyocyte-specific modified mRNA translation system induces cardiomyocyte cell division and cardiac repair.
Magadum A; Sun J; Singh N; Kurian AA; Chepurko E; Fargnoli A; Hajjar R; Zhang J; Zangi L
J Mol Cell Cardiol; 2024 Mar; 188():61-64. PubMed ID: 38301803
[TBL] [Abstract][Full Text] [Related]
32. Engineered adipose-derived stem cells with IGF-1-modified mRNA ameliorates osteoarthritis development.
Wu H; Peng Z; Xu Y; Sheng Z; Liu Y; Liao Y; Wang Y; Wen Y; Yi J; Xie C; Chen X; Hu J; Yan B; Wang H; Yao X; Fu W; Ouyang H
Stem Cell Res Ther; 2022 Jan; 13(1):19. PubMed ID: 35033199
[TBL] [Abstract][Full Text] [Related]
33. MAPK pathway regulated the cardiomyocyte apoptosis in mice with post-infarction heart failure.
Zhang Q; Lu L; Liang T; Liu M; Wang ZL; Zhang PY
Bratisl Lek Listy; 2017; 118(6):339-346. PubMed ID: 28664743
[TBL] [Abstract][Full Text] [Related]
34. Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.
Yockman JW; Kastenmeier A; Erickson HM; Brumbach JG; Whitten MG; Albanil A; Li DY; Kim SW; Bull DA
J Control Release; 2008 Dec; 132(3):260-6. PubMed ID: 18662730
[TBL] [Abstract][Full Text] [Related]
35. β-Arrestin2 Improves Post-Myocardial Infarction Heart Failure via Sarco(endo)plasmic Reticulum Ca
McCrink KA; Maning J; Vu A; Jafferjee M; Marrero C; Brill A; Bathgate-Siryk A; Dabul S; Koch WJ; Lymperopoulos A
Hypertension; 2017 Nov; 70(5):972-981. PubMed ID: 28874462
[TBL] [Abstract][Full Text] [Related]
36. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.
Matsumoto K; Obana M; Kobayashi A; Kihara M; Shioi G; Miyagawa S; Maeda M; Sakata Y; Nakayama H; Sawa Y; Fujio Y
Cardiovasc Res; 2019 Mar; 115(4):765-775. PubMed ID: 30307485
[TBL] [Abstract][Full Text] [Related]
37. Lipidoid mRNA Nanoparticles for Myocardial Delivery in Rodents.
Turnbull IC; Eltoukhy AA; Anderson DG; Costa KD
Methods Mol Biol; 2017; 1521():153-166. PubMed ID: 27910047
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA Meg3 regulates cardiomyocyte apoptosis in myocardial infarction.
Wu H; Zhao ZA; Liu J; Hao K; Yu Y; Han X; Li J; Wang Y; Lei W; Dong N; Shen Z; Hu S
Gene Ther; 2018 Dec; 25(8):511-523. PubMed ID: 30287867
[TBL] [Abstract][Full Text] [Related]
39. Loss of long non-coding RNA CRRL promotes cardiomyocyte regeneration and improves cardiac repair by functioning as a competing endogenous RNA.
Chen G; Li H; Li X; Li B; Zhong L; Huang S; Zheng H; Li M; Jin G; Liao W; Liao Y; Chen Y; Bin J
J Mol Cell Cardiol; 2018 Sep; 122():152-164. PubMed ID: 30125571
[TBL] [Abstract][Full Text] [Related]
40. Transforming Growth Factor-β Receptor III is a Potential Regulator of Ischemia-Induced Cardiomyocyte Apoptosis.
Sun F; Li X; Duan WQ; Tian W; Gao M; Yang J; Wu XY; Huang D; Xia W; Han YN; Wang JX; Liu YX; Dong CJ; Zhao D; Ban T; Chu WF
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28559372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
